Skip to main content
Cesar Arias, MD, Infectious Disease, Houston, TX

Cesar A. Arias MD

Infectious Disease•Houston, TX

Associate Professor, Internal Medicine, University of Texas Medical School,

Join to view full profile

  • 6560 Fannin StreetSuite 1540Houston, TX 77030

  • Phone+1 713-799-9997

  • Fax+1 713-799-2511

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 2 invites waiting!
  • Read the latest clinical news, personalized to your specialty.
Join DoximityAlready have an account?

Summary

  • Dr. Cesar Arias, MD is an infectious disease specialist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Houston Methodist Hospital and is an Associate Professor at University of Texas Medical School,.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2004 - 2008
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2004
  • Escuela Colombiana de Medicina
    Escuela Colombiana de MedicinaClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2007 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • You Just Tested Positive for COVID—Now What?
    You Just Tested Positive for COVID—Now What?September 30th, 2024
  • Updated COVID-19 Vaccines Are Approved Amid a Summer Surge. Here's What to Know
    Updated COVID-19 Vaccines Are Approved Amid a Summer Surge. Here's What to KnowAugust 23rd, 2024
  • 'Mini-Surge' of COVID-19 Joins Flu, RSV to Raise Infection Risk over Holidays, Houston Doctors Say
    'Mini-Surge' of COVID-19 Joins Flu, RSV to Raise Infection Risk over Holidays, Houston Doctors SayDecember 21st, 2022

Grant Support

  • The LiaFSR system and antimicrobial peptide resistance in enterococciMETHODIST HOSPITAL RESEARCH INSTITUTE2018–2031
  • Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)METHODIST HOSPITAL RESEARCH INSTITUTE2024–2029
  • Clinical Impact of the Cefazolin Inoculum EffectMETHODIST HOSPITAL RESEARCH INSTITUTE2025–2028
  • Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)METHODIST HOSPITAL RESEARCH INSTITUTE2020–2026
  • Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)METHODIST HOSPITAL RESEARCH INSTITUTE2020–2026

Dr. Cesar Arias, Dr. Cesar Arias, MD, Dr. C Arias, Dr. Cesar A. Arias